Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 8421
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247314BDBM247314(US9447090, 759)
Affinity DataEC50:  2.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247304BDBM247304(US9447090, 424)
Affinity DataEC50:  2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247299BDBM247299(US9447090, 247)
Affinity DataEC50:  2.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247305BDBM247305(US9447090, 430)
Affinity DataEC50:  2.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247297BDBM247297(US9447090, 179)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247325BDBM247325(US9447090, 829)
Affinity DataEC50:  2.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247294BDBM247294(US9447090, 102)
Affinity DataEC50:  2.80E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247295BDBM247295(US9447090, 119)
Affinity DataEC50:  2.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247317BDBM247317(US9447090, 767)
Affinity DataEC50:  3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247293BDBM247293(US9447090, 12)
Affinity DataEC50:  3.00E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247326BDBM247326(US9447090, 834)
Affinity DataEC50:  4.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247301BDBM247301(US9447090, 321)
Affinity DataEC50:  4.50E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247313BDBM247313(US9447090, 706)
Affinity DataEC50:  4.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247318BDBM247318(US9447090, 772)
Affinity DataEC50:  5.40E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247323BDBM247323(US9447090, 822)
Affinity DataEC50:  5.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247315BDBM247315(US9447090, 760)
Affinity DataEC50:  5.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247300BDBM247300(US9447090, 251)
Affinity DataEC50:  6.10E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247310BDBM247310(US9447090, 702)
Affinity DataEC50:  6.20E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247320BDBM247320(US9447090, 778)
Affinity DataEC50:  6.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247298BDBM247298(US9447090, 226)
Affinity DataEC50:  6.70E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247303BDBM247303(US9447090, 341)
Affinity DataEC50:  6.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247306BDBM247306(US9447090, 434)
Affinity DataEC50:  7.30E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247324BDBM247324(US9447090, 828)
Affinity DataEC50:  7.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247322BDBM247322(US9447090, 798)
Affinity DataEC50:  8.60E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247321BDBM247321(US9447090, 797)
Affinity DataEC50:  8.90E+3nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247311BDBM247311(US9447090, 704)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247296BDBM247296(US9447090, 126)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247312BDBM247312(US9447090, 705)
Affinity DataEC50:  1.10E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247302BDBM247302(US9447090, 323)
Affinity DataEC50:  1.30E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247319BDBM247319(US9447090, 776)
Affinity DataEC50:  1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247309BDBM247309(US9447090, 699)
Affinity DataEC50:  1.50E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247307BDBM247307(US9447090, 693)
Affinity DataEC50:  1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247316BDBM247316(US9447090, 766)
Affinity DataEC50:  1.70E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 247308BDBM247308(US9447090, 698)
Affinity DataEC50:  1.90E+4nMT: 2°CAssay Description:The activity of sGC was evaluated by measuring the amount of a cyclic guanosine monophosphate (cGMP) which is produced by human purified sGC. A test ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
US Patent